Future studies should increase the sample size to investigate the correlation between the infiltration of GZMA+IFN-γ+CD8+TILs and the prognosis of colon cancer patients, to determine whether this ratio can serve as a reliable biomarker for prognosis assessment and treatment efficacy monitoring in colon cancer. The gene discussed is IFNG; the disease is colonic neoplasm.